BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37150358)

  • 1. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort.
    Giannella M; Huth M; Righi E; Hasenauer J; Marconi L; Konnova A; Gupta A; Hotterbeekx A; Berkell M; Palacios-Baena ZR; Morelli MC; Tamè M; Busutti M; Potena L; Salvaterra E; ; Feltrin G; Gerosa G; Furian L; Burra P; Piano S; Cillo U; Cananzi M; Loy M; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Baño JR; Lazzarotto T; Viale P; Tacconelli E
    Clin Microbiol Infect; 2023 Aug; 29(8):1084.e1-1084.e7. PubMed ID: 37150358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
    Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
    Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
    Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
    Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
    Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
    Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
    Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
    Front Immunol; 2022; 13():832501. PubMed ID: 35281023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.
    Angelico R; Romano F; Coppola L; Materazzo M; Pedini D; Santicchia MS; Cacciola R; Toti L; Sarmati L; Tisone G
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138204
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort.
    Giannella M; Righi E; Pascale R; Rinaldi M; Caroccia N; Gamberini C; Palacios-Baena ZR; Caponcello G; Morelli MC; Tamè M; Busutti M; Comai G; Potena L; Salvaterra E; Feltrin G; Cillo U; Gerosa G; Cananzi M; Piano S; Benetti E; Burra P; Loy M; Furian L; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Abedini M; Boffetta P; Rodríguez-Baño J; Lazzarotto T; Viale P; Tacconelli E; On Behalf Of The Orchestra Study Group Workpackage
    Microorganisms; 2022 May; 10(5):. PubMed ID: 35630462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral response to heterologous prime-booster vaccination in heart transplant recipients aged 18-70 years primed with a viral vector SARS-CoV-2 vaccine.
    Tanner R; Starr N; Perez-Garcia CN; Chan G; Dempsey E; Heffernan E; Lynch B; Hannan MM; Joyce E
    Transpl Infect Dis; 2022 Dec; 24(6):e13935. PubMed ID: 35980217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation.
    Alejo JL; Mitchell J; Chiang TP; Chang A; Abedon AT; Werbel WA; Boyarsky BJ; Zeiser LB; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Moore LW; Guha A; Huang HJ; Knight RJ; Gaber AO; Ghobrial RM; Garonzik-Wang JM; Segev DL; Bae S
    Transplantation; 2022 Oct; 106(10):e452-e460. PubMed ID: 35859275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients.
    Natori Y; Martin E; Mattiazzi A; Arosemena L; Ortigosa-Goggins M; Shobana S; Roth D; Kupin WL; Burke GW; Ciancio G; Morsi M; Phancao A; Munagala MR; Butrous H; Manickavel S; Sinha N; Sota K; Pallikkuth S; Bini J; Simkins J; Anjan S; Vianna RM; Guerra G
    Transpl Int; 2023; 36():10938. PubMed ID: 37091963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
    J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
    Giannella M; Pierrotti LC; Helanterä I; Manuel O
    Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
    J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
    Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
    Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
    Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.